Kenneth Frazier - Merck Insider

Chairman, CEO and Pres

Mr. Kenneth C. Frazier is Chairman of the Board, President, Chief Executive Officer of Merck Co., Inc. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company and Merck Sharp Dohme Corporationration
Age: 60  Chairman Since 2011      
908 735-1500
Kenneth Frazier EducationFrazier also served as Executive Vice President and General Counsel of Merck Sharp & Dohme Corporationration . Director, Exxon Mobil Corporationrationration since 2009 and Pharmaceutical Research and Manufacturers of America since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Management Efficiency

The company has Return on Asset of 6.58 % which means that on every $100 spent on asset it made $6.58 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 10.4 % implying that it generated $10.4 on every 100 dollars invested.
The company has 28.51 B in debt with debt to equity (D/E) ratio of 71.1 . This implies that the company may be unable to create cash to meet all of its financial commitments. Merck Co Inc has Current Ratio of 1.56 which is typical for the industry and considered as normal.

Similar Executives

Entity Summary

Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Equity Search Now

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
Hide  View All  Next  Launch Equity Search
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Merck Co Inc to your portfolio

Top Management

Merck Co Inc Leadership Team
Thomas Glocer, Director
C Kidder, Director
Craig Thompson, Director
Rochelle Lazarus, Director
Michael Rosenblatt, President, Ph.D
Wendell Weeks, Director
Michael Holston, President
Paul Rothman, Director
Adele Ambrose, President
Joseph Romanelli, Executive
Mirian GraddickWeir, President, Ph.D
Peter Wendell, Director
Leslie Brun, Director
Julie Gerberding, President
Pamela Craig, Director, MBA
Patricia Russo, Director
Willie Deese, President
Rita Karachun, SVP
Robert Davis, CFO
Robert Kidder, Director
Thomas Cech, Director, Ph.D
Clark Golestani, EVP
William Harrison, Director
Bruce Kuhlik, EVP
Roger Perlmutter, President, Ph.D
Sanat Chattopadhyay, President
Adam Schechter, President
Carlos Represas, Director
Richard DeLuca, President
Kenneth Frazier, Chairman

Stock Performance

Merck Performance Indicators